Study on health effects of Japanese yam propagules

Not Applicable

• Conditions: Healthy volunteers

• Registration Number: JPRN-UMIN000029619
• Lead Sponsor: Kanagawa Insutitute of Industrial Sciense and Technology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-10-19
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

Not provided

Exclusion Criteria

Volunteers whose blood test values (FPG, Hb1Ac, T-cho, TG, LDL-cho, HDL-cho, CRE, RBC, Hb, Ht) at the time of screening are in decision criteria C(follow-up), D1(requires further testing) or D2(requires treatment) of Japan Society of Ningen Dock. Volunteers whose blood test values (ALT, AST,gamma-GT, ALP, LD, T-Bil) at the time of screening are in decision criteria D1(requires further testing) or D2(requires treatment) of Japan Society of Ningen Dock. Patients with dyslipidemia or with diabetes under medical treatment or on the use of medicine. Volunteers with a risk of causing drug or food (especially yam and wheat) allergic symptoms. Volunteers taking drugs and supplements which affect the study. Volunteers who participate in other clinical trials within the last one month prior to the current clinical trial. Volunteers have donated blood more than 400mL within the last three months or more than 200mL within the last one month before the date of consent. Volunteers with any other medical reasons judged to be inappropriate by chief investigater.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
iver function (ALT, AST, gamma-GT, ALP, LD, T-Bil)

Secondary Outcome Measures

Name	Time	Method
Blood RNA analysis, Fecal (intestinal) mocroflora analysis, Multimodal homeostasis evaluation systems